Online Inquiry
Prostate Cancer Spheroid Development
Prostate cancer spheroids are an important in vitro model for studying the biological behavior of tumors, including tumor heterogeneity, drug response, and the effects of the tumor microenvironment. Alfa Cytology offers a one-stop prostate cancer spheroids development service, ensuring that your research projects can move forward with efficiency and precision.
Introduction to Prostate Cancer Spheroids
Prostate cancer spheroids are three-dimensional (3D) cell culture models that mimic the mechanical tension in tumor tissues and provide a more representative pathophysiological model than traditional 2D cultures. These cell spheroids are formed in vitro by culturing prostate cancer cell lines such as LNCaP, PC3, and VCaP. They are able to replicate the 3D structure of tumors and cell-cell interactions, which is crucial for studying the role of tumor heterogeneity in cancer development, prognosis, and treatment.
Fig. 1 LNCaP spheroid
morphology and doubling time. (Bastian, J. L. D., et al. 2024)
Differences Between Spheroids and Organoids in Prostate Cancer
The main differences between spheroids and organoids in prostate cancer are as follows.
- Size
organoids are large and vary by organ type; cell spheres are small, typically a few hundred micrometers. - Structure and Function
Organoids are miniature organs with structure/function similar to real organs, while cell spheres are simplified 3D cell aggregates. - Developmental Drivers
Organoid formation is driven by internal developmental processes, while cell spheres develop primarily through intercellular adhesion. - Maintenance Duration
Organoids are derived from and maintain stem cell populations during in vitro culture, which ensures their long-term viability. In contrast, long-term culture of tissue-derived cell spheres is challenging, possibly due to the technical difficulties inherent in extracting and maintaining living cells.
- Degree of Complexity
Organoids have high complexity and contain multiple cell types and layers, similar to organ tissues with different regions. Cell spheres, on the other hand, have a single structure, are less organized, and have relatively homogeneous cell types. - Culturing Requirements
Organoids require complex extracellular matrix (ECM) scaffolds such as Matrigel, whereas cell spheres are relatively easy to culture and are usually grown in suspension. - Functional mimicry
Organoids are able to mimic some organ functions, such as secretion and signaling, while cell spheres lack organ-like functions.
Our Services
Alfa Cytology is dedicated to offering a full spectrum of spheroid development services for prostate cancer studies, encompassing the creation and refinement of tailored 3D spheroid models. Our expert team is devoted to fulfilling your precise requirements for spherical cell cultures in the realms of tumor aggression analysis, drug resistance profiling, and tumor microenvironment investigations.
Workflow for Prostate Cancer Spheroid Development
Cell Collection
Cell Culture
Spheroid Formation
Functional Analysis
One-Stop Solutions for Prostate Cancer Spheroid Development
|
|
|
| Type | Primary Cell Spherical Model | Prostate Cancer Spherical Model |
| Source | Primary cell spheroids are directly sourced from prostate cancer tumor tissue, forming 3D structures through in vitro cultivation of fresh primary cells. | Prostate cancer spheroids are developed from cell lines or patient cells, aggregating into spheres under specific conditions like low-attachment plates or suspension culture. |
| Application | Primary cell spheroids replicate tumor microenvironments and interactions, maintaining diversity and heterogeneity, and are used for studying early tumor stages, drug responses, and personalized therapies. | Primary cell spheroids replicate tumor microenvironments and interactions, maintaining diversity and heterogeneity, and are used for studying early tumor stages, drug responses, and personalized therapies. |
Case Study
Development of a 3D Spheroid Model for Prostate Cancer
We have successfully established compact and morphologically uniform 3D prostate cancer spheroid models utilizing proprietary standard operating procedures and optimized culture media systems. This platform encompasses a diverse range of models, including established cell lines, drug-resistant variants, and primary patient-derived tumor cells.
- Establishment of a 3D Spheroid Model for Prostate Cancer
LNCaP prostate cancer cells were seeded into a 96-well microplate at a volume of 100 µL per well. Control wells received 100 µL of cell-free 3D spheroid culture medium. The microplates were then maintained in a humidified incubator at 37°C and 5% CO₂. Spheroid formation and growth were monitored periodically, followed by the assessment of cell viability (Fig. 2).
Fig. 2 LNCaP 3D spheroid observation
- Drug Efficacy Evaluation in 3D Prostate Cancer Spheroids
Spheroids were visualized using an inverted microscope, with images captured at each designated time point. Image analysis software was employed to quantify changes in cross-sectional area, allowing for the assessment of 3D spheroid assembly and growth kinetics. Cell proliferation was subsequently determined using an MTT assay kit (Fig. 3).
Fig. 2 LNCaP 3D spheroid observation
With extensive experience and advanced platforms, we offers a one-stop prostate cancer spheroids development service. We guarantee that your research endeavors are equipped with superior, dependable prostate cancer spheroid models. If you are interested in our services, please don't hesitate to contact us for further information and pricing details.
Reference
- Bastian, J. L. D., et al. Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model. Scientific reports. 2024, 14(1): 8835.
For research use only.